USSTOCK.TODAY
Market Closed
Log in Sign up

Growth of Public Companies in AI-Driven Drug Discovery

FinanceWire · ·by G4L

ANT
ANT Anthropic PBC
$96.86 +16.70%
View chart & analysis →
  1. 1AI is becoming part of the drug discovery process, and several public companies are finding opportunities in this field.
  2. 2Anthropic recently began a roadshow for its Class A common stock initial public offering (IPO).
  3. 3Schrödinger announced in its Q3 2026 earnings report that its annual contract value increased 17% year-over-year to $44.7 million.

So what's the key point?

Companies using artificial intelligence to create medicines are growing. Schrödinger is finding opportunities as its contract value increased by 17%.

Source FinanceWire · View original ↗

Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →